EPB0241 HIV Rapid testing as a screening test for HIV-Exposed children on the OPPTIM Study in South AfricaE-posterAntiretroviral therapies and clinical issues in infants, children and adolescents
EPB0242 Adherence to antiretroviral therapy (ART), drug resistance, and their impact on evolving viral suppression among a long-term cohort of youth living with perinatal HIV infection in western KenyaE-posterAntiretroviral therapies and clinical issues in infants, children and adolescents
EPB0243 Underlying causes of death in children living with HIV in TanzaniaE-posterAntiretroviral therapies and clinical issues in infants, children and adolescents
EPB0244 Viral suppression in the era of transition to Dolutegravir-based therapy in Cameroon: children at high risk of virological failureE-posterAntiretroviral therapies and clinical issues in infants, children and adolescents
EPB0245 A decade of care: long term outcomes of a paediatric HIV cohortE-posterAntiretroviral therapies and clinical issues in infants, children and adolescents
EPB0246 Spanish cohort of HIV mother-infant pairs: current epidemiology and perinatal transmission (2020-2022)E-posterAntiretroviral therapies and clinical issues in infants, children and adolescents
EPB0247 Uptake and outcomes of tenofovir alafenamide fumarate (TAF) –based therapy in children and young people living with HIV (CLWHIV) in the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC)E-posterAntiretroviral therapies and clinical issues in infants, children and adolescents
EPB0248 Young adults who acquired HIV perinatally have poorer viral suppression than those who acquired HIV later in life: a population survey in ZimbabweE-posterAntiretroviral therapies and clinical issues in infants, children and adolescents
EPB0249 Early ART and mental health outcomes by school-age and adolescent years of life: a longitudinal comparative study of HIV-exposed and community control adolescents from UgandaE-posterAntiretroviral therapies and clinical issues in infants, children and adolescents
EPB0250 Efficacy and safety of dolutegravir/lamivudine (DTG/3TC) in antiretroviral therapy (ART)-naive adolescents living with HIV-1: DANCE study Week 96 resultsE-posterAntiretroviral therapies and clinical issues in infants, children and adolescents
51 - 60 of 1427 items